Medications for Acquired Thrombotic Thrombocytopenic Purpura

1 result
  • cablivi - caplacizumab

    (Caplacizumab)
    Genzyme Corporation
    Cablivi treats acquired thrombotic thrombocytopenic purpura (aTTP) in adults and pediatric patients 12 and older, used alongside plasma exchange and immunosuppressive therapy.